ALOX5 and breast cancer: Our prior study demonstrated that PIK3CA mutations facilitate immune evasion in breast cancer by recruiting myeloid-derived suppressor cells (MDSCs) through activation of the 5-lipoxygenase (5-LOX)-dependent arachidonic acid pathway [14].